相关实验视频

Updated: Jan 10, 2026

Rapid and Efficient Generation of Recombinant Human Pluripotent Stem Cells by Recombinase-mediated Cassette Exchange in the AAVS1 Locus

Rapid and Efficient Generation of Recombinant Human Pluripotent Stem Cells by Recombinase-mediated Cassette Exchange in the AAVS1 Locus

Published on: November 20, 2016

VHL基因修复支持RCC重编程到iPSC,但不确保线路稳定性

Zsuzsanna Lichner^1,2, Yasaman Shamshirgaran³, Katarzyna Pieczonka^4,5

¹Lunenfeld Tanenbaum Research Institute, Mt. Sinai Hospital, Toronto, ON M5G 1X5, Canada.

|November 27, 2025

概括

将清细胞细胞癌 (ccRCC) 细胞重新编程为干细胞是一项挑战. 虽然恢复VHL基因有助于重编程,但ccRCC中的其他遗传突变可能会阻止稳定的多能性.

科学领域:

癌症生物学癌症生物学
干细胞生物学干细胞生物学
再生医学是一种再生医学.

背景情况:

建模癌前阶段有助于理解早期癌症转变.
癌症劫持发育途径,这表明重新编程可以模拟癌前期.
有机模型为个性化,有针对性的癌症治疗提供了潜力.

研究的目的:

通过重编程癌细胞来建模癌前清细胞细胞癌 (ccRCC).
研究希佩尔-林道基因 (VHL) 在ccRCC重编程中的作用.
评估有机体模型在研究早期癌症发展方面的潜力.

主要方法:

试图重新编程患者衍生的ccRCC和正常的上皮细胞系.
为了细胞重编程,利用了lentivirus或环节性重编程载体.
在ccRCC细胞中重新表达VHL基因,以评估其对重编程效率的影响.

主要成果:

正常的细胞有效地重新编程,而ccRCC细胞失败了.
重新表达VHL恢复了ccRCC细胞中的上皮表型和氧化代谢,但没有实现稳定的重编程.
经VHL校正的ccRCC细胞产生了NANOG+细胞,但仍然依赖于重编程因素.

结论:

对于ccRCC细胞的稳定细胞重编程,VHL表达是必要的,但不足的.
在ccRCC细胞中的额外遗传病变可能会阻止多能状态的稳定.
需要进一步的研究来克服ccRCC中的重编程障碍,以实现有效的建模.

关键词:

这是VHLVHL.在癌症细胞-iPSCC.癌症模型癌症模型清细胞细胞癌是什么?葡萄糖溶解法葡萄糖溶解法氧化酸化是一种氧化酸化.重编程是重新编程.

更多相关视频

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

相关概念视频

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...

Methods of Nuclear Reprogramming

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells:

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...